March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Opa1/twinkle Double Trouble Underlying ‘Doa Plus’ Phenotype
Author Affiliations & Notes
  • Valerio Carelli
    IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurological Sciences,
    University of Bologna, Bologna, Italy
  • Leonardo Caporali
    IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurological Sciences,
    University of Bologna, Bologna, Italy
  • Rocco Liguori
    IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurological Sciences,
    University of Bologna, Bologna, Italy
  • Chiara La Morgia
    IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurological Sciences,
    University of Bologna, Bologna, Italy
  • Piero Barboni
    Studio d'Azeglio, Bologna, Italy
  • Raffaele Lodi
    MR Functional Unit, Department of Internal Medicine, Aging and Nephrology,
    University of Bologna, Bologna, Italy
  • Maria L. Valentino
    IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurological Sciences,
    University of Bologna, Bologna, Italy
  • Footnotes
    Commercial Relationships  Valerio Carelli, None; Leonardo Caporali, None; Rocco Liguori, None; Chiara La Morgia, None; Piero Barboni, None; Raffaele Lodi, None; Maria L. Valentino, None
  • Footnotes
    Support  E-Rare ERMION grant JTC2009
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1555. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Valerio Carelli, Leonardo Caporali, Rocco Liguori, Chiara La Morgia, Piero Barboni, Raffaele Lodi, Maria L. Valentino; Opa1/twinkle Double Trouble Underlying ‘Doa Plus’ Phenotype. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1555.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To report the complex molecular features of a patient with dominant chronic progressive external ophthalmoplegia (adCPEO) inherited from the maternal side and dominant optic atrophy (DOA) inherited from the paternal side. The combination of CPEO and optic atrophy defines the recently described phenotype of "DOA plus", associated with accumulation of mitochondrial DNA (mtDNA) multiple deletions in the skeletal muscle.

 
Methods:
 

The proband, a 42 years old male, had bilateral optic atrophy, reduced visual acuity and central scotoma since 15 years. After 30 he progressively developed ptosis and CPEO, with pathologically elevated creatine kinase and lactic acid. His mother also had ptosis and CPEO, but without visual complains. A second patient from the same geographical area, possibly related to the proband on the paternal side, had optic atrophy and slowly progressive loss of central vision since childhood, similar to his mother. This patient also had pathologically elevated lactic acid after exercise. Both patients were investigated by optical coherence tomography (OCT) (Stratus), muscle biopsy, brain and muscle MR-spectroscopy, and genetic analysis.

 
Results:
 

Both patients had reduced retinal nerve fiber layer thickness at OCT, mitochondrial myopathy with numerous cytochrome c oxidase negative fibers and accumulation of mtDNA multiple deletions. MR spectroscopy showed mild bioenergetic impairment in muscle and brain in the second patient, whereas was essentially normal in the proband. Screening of the known genes associated with defective mtDNA maintenance was positive for the heterozygous c.907C>T mutation (p.Arg303Trp) in the PEO1 gene (Twinkle) in the proband. He was also positive for the heterozygous c.703C>T mutation (p.Arg235stop) in exon 7 of the OPA1 gene. His mother had only the PEO1 mutation. The second patient carried only the same OPA1 mutation on the same haplotype, suggesting a common founder.

 
Conclusions:
 

This report highlights the complex molecular basis of a "DOA plus" case combining CPEO/ptosis, optic atrophy and mtDNA multiple deletions. The Twinkle mutation was responsible for the adCPEO/ptosis, inherited from the mother. The combined OPA1 mutation was responsible for the optic atrophy. However, the OPA1 mutation alone in the second patient was still associated with mitochondrial myopahty and mtDNA multiple deletions, pointing to defective mtDNA maintenance as a common consequence shared by both Twinkle and OPA1 mutations.

 
Keywords: mitochondria • optic nerve • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×